Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy

Objectives:  The objective was to develop a valid and reliable health‐related quality of life (HRQOL) assessment tool to measure the functional and health status of patients with minimal hepatic encephalopathy (mHE). Methods:  Items potentially affecting the HRQOL of these patients were identified,...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 24; no. 3; pp. 408 - 415
Main Authors Zhou, Ying-qun, Chen, Shi-yao, Jiang, Lin-di, Guo, Chuan-yong, Shen, Zhen-yu, Huang, Pei-xing, Wang, Ji-yao
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.03.2009
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives:  The objective was to develop a valid and reliable health‐related quality of life (HRQOL) assessment tool to measure the functional and health status of patients with minimal hepatic encephalopathy (mHE). Methods:  Items potentially affecting the HRQOL of these patients were identified, based on the responses from 53 patients with minimal hepatic encephalopathy, from seven liver experts, four epidemiologists and from a PubMed search of the literature. Results were explored using factor analysis and redundant questions were eliminated. The final stated questionnaire was used in 178 patients with mHE to evaluate its reliability and validity. Results:  Thirty‐five items proved to be important for 32 respondents in the item reduction sample. The final instrument included five domains (30 items) which were shown as follows: physical functioning (8 items), psychological well‐being (7 items), symptoms/side effects (7 items), social functioning (4 items) and general‐health (4 items). An inter‐item correlation for each of the five domains ranged from 0.220 to 0.776, with a mean of 0.280. Cronbach's alpha for above five domains was 0.8775, 0.8446, 0.8360, 0.7087 and 0.7016 respectively. The test‐retest coefficients for the five domains were 0.94, 0.93, 0.96, 0.82 and 0.83 respectively. Factor analysis showed preservation of five components structure. Cumulative variance of principal components was 63.12%. Patients with more advanced disease seemed to have more impairment of their well‐being, especially in the symptoms/side effects domain. Conclusions:  The instrument is short, easy to administer and is of good validity and reliability in patients with mHE.
Bibliography:ark:/67375/WNG-TC25J4SC-3
istex:24E534B5BAC7579C0C5F48AF20A01F212FDE7189
ArticleID:JGH5678
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0815-9319
1440-1746
DOI:10.1111/j.1440-1746.2008.05678.x